Ramón Gomis1, Sara Artola2, Pedro Conthe3, Josep Vidal4, Ricard Casamor5, Beatriu Font5. 1. Servicio de Endocrinología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España. Electronic address: rgomis@clinic.ub.es. 2. Centro de Salud María Jesús Hereza, Leganés, Madrid, España. 3. Departamento de Medicina Interna, Hospital General Gregorio Marañón, Madrid, España. 4. Servicio de Endocrinología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España. 5. Novartis Farmacéutica, S.A., Barcelona, España.
Abstract
BACKGROUND AND OBJECTIVE: The increase in the prevalence of type 2 diabetes mellitus (T2DM) is related to the increase of obesity. We aimed to determine the Spanish prevalence of T2DM in patients with overweight or obesity attended by either family or specialist physicians. PATIENTS AND METHOD: Cross-sectional, multicenter and simultaneous 2-phase design, performed under clinical conditions. Phase A was designed to determine T2DM prevalence: 169,023 patients were recruited. Phase B was designed to define socio-demographic, clinical and metabolic profile of T2DM according to the body mass index (BMI): 7,754 patients were included. RESULTS: T2DM prevalence in overweight or obese patients was 23.6%; 17.8% of overweight patients were diabetic and T2DM was present in 34.8% of obese people. According to sex, 20.2% of men and 16.4% of women had T2DM. Overall, the mean of risk factors related to T2DM was 4.4 (SD 0,8); out of them, 92.6% patients had dyslipidemia, 73.7% hypertension and 62.5% performed a low physical activity. 37.8% of diabetic patients had vascular involvement. Only 43.1% of patients showed a proper metabolic control of T2DM (glycosilated hemoglobin<7%). CONCLUSIONS: T2DM is related to overweight and obesity and higher the BMI is, higher the T2DM prevalence. Dyslipidemia, hypertension and a low physical activity in diabetic patients are more frequent when BMI increases. Patients with inadequate metabolic control have a higher BMI.
BACKGROUND AND OBJECTIVE: The increase in the prevalence of type 2 diabetes mellitus (T2DM) is related to the increase of obesity. We aimed to determine the Spanish prevalence of T2DM in patients with overweight or obesity attended by either family or specialist physicians. PATIENTS AND METHOD: Cross-sectional, multicenter and simultaneous 2-phase design, performed under clinical conditions. Phase A was designed to determine T2DM prevalence: 169,023 patients were recruited. Phase B was designed to define socio-demographic, clinical and metabolic profile of T2DM according to the body mass index (BMI): 7,754 patients were included. RESULTS: T2DM prevalence in overweight or obesepatients was 23.6%; 17.8% of overweight patients were diabetic and T2DM was present in 34.8% of obesepeople. According to sex, 20.2% of men and 16.4% of women had T2DM. Overall, the mean of risk factors related to T2DM was 4.4 (SD 0,8); out of them, 92.6% patients had dyslipidemia, 73.7% hypertension and 62.5% performed a low physical activity. 37.8% of diabeticpatients had vascular involvement. Only 43.1% of patients showed a proper metabolic control of T2DM (glycosilated hemoglobin<7%). CONCLUSIONS: T2DM is related to overweight and obesity and higher the BMI is, higher the T2DM prevalence. Dyslipidemia, hypertension and a low physical activity in diabeticpatients are more frequent when BMI increases. Patients with inadequate metabolic control have a higher BMI.
Keywords:
Body mass index; Cross-sectional studies; Diabetes mellitus; Estudios transversales; Obesidad; Obesity; Prevalence; Prevalencia; Índice de masa corporal
Authors: Luis A Vázquez; Ángel Rodríguez; Javier Salvador; Juan F Ascaso; Helmut Petto; Jesús Reviriego Journal: BMC Cardiovasc Disord Date: 2014-11-01 Impact factor: 2.298
Authors: Maria Valeria Jimenez-Baez; Horacio Marquez-Gonzalez; Rodolfo Barcenas-Contreras; Carlos Morales Montoya; Laura Fatima Espinosa-Garcia Journal: Colomb Med (Cali) Date: 2015-03-30
Authors: Arantzazu Arrospide; Oliver Ibarrondo; Iván Castilla; Igor Larrañaga; Javier Mar Journal: Med Decis Making Date: 2021-10-11 Impact factor: 2.583
Authors: Isabel Jiménez-Trujillo; Montserrat González-Pascual; Rodrigo Jiménez-García; Valentín Hernández-Barrera; José M de Miguel-Yanes; Manuel Méndez-Bailón; Javier de Miguel-Diez; Miguel Ángel Salinero-Fort; Napoleón Perez-Farinos; Pilar Carrasco-Garrido; Ana López-de-Andrés Journal: Medicine (Baltimore) Date: 2016-05 Impact factor: 1.889